These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 32921062)
1. Germline mutations and prostate cancer: is it time to change treatment algorithms? Telvizian T; Mukherji D Chin Clin Oncol; 2020 Oct; 9(5):65. PubMed ID: 32921062 [TBL] [Abstract][Full Text] [Related]
2. Bringing Prostate Cancer Germline Genetics into Clinical Practice. Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411 [TBL] [Abstract][Full Text] [Related]
3. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer. Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341 [TBL] [Abstract][Full Text] [Related]
4. Germline and Somatic Mutations in Prostate Cancer for the Clinician. Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines. Nicolosi P; Ledet E; Yang S; Michalski S; Freschi B; O'Leary E; Esplin ED; Nussbaum RL; Sartor O JAMA Oncol; 2019 Apr; 5(4):523-528. PubMed ID: 30730552 [TBL] [Abstract][Full Text] [Related]
7. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide. Antonarakis ES; Lu C; Luber B; Liang C; Wang H; Chen Y; Silberstein JL; Piana D; Lai Z; Chen Y; Isaacs WB; Luo J Eur Urol; 2018 Aug; 74(2):218-225. PubMed ID: 29439820 [TBL] [Abstract][Full Text] [Related]
8. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine. Marino F; Totaro A; Gandi C; Bientinesi R; Moretto S; Gavi F; Pierconti F; Iacovelli R; Bassi P; Sacco E Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):655-664. PubMed ID: 36434163 [TBL] [Abstract][Full Text] [Related]
9. Germline and somatic mutations in prostate cancer: Implications for treatment. Chalker C; Chun B; Sokolova AO Curr Probl Cancer; 2024 Jun; 50():101101. PubMed ID: 38718711 [TBL] [Abstract][Full Text] [Related]
10. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium. Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN; Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481 [TBL] [Abstract][Full Text] [Related]
12. Germline Testing in Prostate Cancer: When and Who to Test. Sokolova A; Cheng H Oncology (Williston Park); 2021 Oct; 35(10):645-653. PubMed ID: 34669358 [TBL] [Abstract][Full Text] [Related]
13. Germline Mutations and Ancestry in Prostate Cancer. Bataba E; Babcock K; Isensee KA; Eldhose B; Kohaar I; Chesnut GT; Dobi A Curr Oncol Rep; 2024 Feb; 26(2):175-180. PubMed ID: 38265515 [TBL] [Abstract][Full Text] [Related]
14. Genetics of prostate cancer and its utility in treatment and screening. Benafif S; Ni Raghallaigh H; McHugh J; Eeles R Adv Genet; 2021; 108():147-199. PubMed ID: 34844712 [TBL] [Abstract][Full Text] [Related]
16. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53. Freedland SJ; Aronson WJ Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070 [TBL] [Abstract][Full Text] [Related]
17. Utilization of genetic testing in men with advanced prostate cancer. Aguiar JA; Li EV; Siddiqui MR; Soliman MA; Kumar SKSR; Schaeffer EM; Keeter MK; Brown CH; Szymaniak BM; Ross AE Prostate; 2023 May; 83(6):516-523. PubMed ID: 36591888 [TBL] [Abstract][Full Text] [Related]
18. Germline testing in those at risk of prostate cancer. Carroll PR; Witte JS; Parsons JK Can J Urol; 2019 Oct; 26(5 Suppl 2):31-33. PubMed ID: 31629425 [TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Screening in a New Era of Genetics. Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982 [TBL] [Abstract][Full Text] [Related]
20. Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer. Mamidi TKK; Wu J; Hicks C BMC Cancer; 2019 Mar; 19(1):229. PubMed ID: 30871495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]